These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 9517397
21. De novo design and synthesis of cyclic and linear peptides to mimic the binding cassette of human relaxin. Hossain MA, Bathgate RA, Tregear G, Wade JD. Ann N Y Acad Sci; 2009 Apr; 1160():16-9. PubMed ID: 19416152 [Abstract] [Full Text] [Related]
24. Chemical synthesis of a Zwitterhormon, insulaxin, and of a relaxin-like bombyxin derivative. Büllesbach EE, Steinetz BG, Schwabe C. Biochemistry; 1996 Jul 30; 35(30):9754-60. PubMed ID: 8703947 [Abstract] [Full Text] [Related]
26. LGR7-truncate is a splice variant of the relaxin receptor LGR7 and is a relaxin antagonist in vitro. Scott DJ, Tregear GW, Bathgate RA. Ann N Y Acad Sci; 2005 May 30; 1041():22-6. PubMed ID: 15956683 [Abstract] [Full Text] [Related]
27. Relaxin binding in the rat heart atrium. Osheroff PL, Cronin MJ, Lofgren JA. Proc Natl Acad Sci U S A; 1992 Mar 15; 89(6):2384-8. PubMed ID: 1312720 [Abstract] [Full Text] [Related]
28. Receptor mechanisms involved in the 5-HT-induced inotropic action in the rat isolated atrium. Läer S, Remmers F, Scholz H, Stein B, Müller FU, Neumann J. Br J Pharmacol; 1998 Mar 15; 123(6):1182-8. PubMed ID: 9559903 [Abstract] [Full Text] [Related]
33. Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8). Halls ML, Bond CP, Sudo S, Kumagai J, Ferraro T, Layfield S, Bathgate RA, Summers RJ. J Pharmacol Exp Ther; 2005 May 15; 313(2):677-87. PubMed ID: 15649866 [Abstract] [Full Text] [Related]
34. Roles of the receptor, the ligand, and the cell in the signal transduction pathways utilized by the relaxin family peptide receptors 1-3. Summers RJ, Bathgate RA, Wade JD, van der Westhuizen ET, Halls ML. Ann N Y Acad Sci; 2009 Apr 15; 1160():99-104. PubMed ID: 19416167 [Abstract] [Full Text] [Related]
36. International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides. Bathgate RA, Ivell R, Sanborn BM, Sherwood OD, Summers RJ. Pharmacol Rev; 2006 Mar 15; 58(1):7-31. PubMed ID: 16507880 [Abstract] [Full Text] [Related]
37. Characterization of the rat INSL3 receptor. Scott DJ, Fu P, Shen PJ, Gundlach A, Layfield S, Riesewijk A, Tomiyama H, Hutson JM, Tregear GW, Bathgate RA. Ann N Y Acad Sci; 2005 May 15; 1041():13-6. PubMed ID: 15956681 [Abstract] [Full Text] [Related]
38. Modeling the primary hormone-binding site of RXFP1 and RXFP2. Scott DJ, Tregear GW, Bathgate RA. Ann N Y Acad Sci; 2009 Apr 15; 1160():74-7. PubMed ID: 19416162 [Abstract] [Full Text] [Related]
39. Relaxin-induced changes in renal function and RXFP1 receptor expression in the female rat. Bogzil AH, Ashton N. Ann N Y Acad Sci; 2009 Apr 15; 1160():313-6. PubMed ID: 19416210 [Abstract] [Full Text] [Related]
40. Synthetic cross-links arrest the C-terminal region of the relaxin-like factor in an active conformation. Büllesbach EE, Schwabe C. Biochemistry; 2004 Jun 29; 43(25):8021-8. PubMed ID: 15209497 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]